
Medpace Holdings (MEDP) Stock Forecast & Price Target
Medpace Holdings (MEDP) Analyst Ratings
Bulls say
Medpace Holdings is poised for growth, with expectations of passthrough revenues increasing by 200-300 basis points in the second half of the year, compared to elevated levels in the second quarter. The company is experiencing positive momentum due to higher request-for-proposal (RFP) volumes observed in the first quarter, pointing to robust demand for its services. Additionally, Medpace anticipates a strong book-to-bill ratio, potentially exceeding 1.15x in the third quarter, reflecting healthy operational efficiency and demand stability.
Bears say
Medpace Holdings has experienced backlog cancellations that remain at the upper range of normal, indicating potential instability in customer demand. Despite a slight improvement in cancellations in Q2, the company has not provided quantifiable projections for growth in Direct Service revenue, contributing to uncertainty regarding future revenue streams. Additionally, the updated adjusted EBITDA estimates for 2025 and 2026 have been revised upward, but this adjustment reflects rising direct service costs and anticipated declines in passthroughs, highlighting ongoing concerns about cost management and profitability.
This aggregate rating is based on analysts' research of Medpace Holdings and is not a guaranteed prediction by Public.com or investment advice.
Medpace Holdings (MEDP) Analyst Forecast & Price Prediction
Start investing in Medpace Holdings (MEDP)
Order type
Buy in
Order amount
Est. shares
0 shares